SITC 2024 Advances in Cancer Immunotherapy Series
We’re excited to announce SITC’s 2024 Advances in Cancer Immunotherapy (ACI) educational series, which offers in-depth clinical training in immunotherapy treatment for a variety of disease states and topics from experts in the field. The ACI programs aim to engage practicing clinical oncologists, advanced practitioners, nurses, pharmacists, emergency physicians, and other allied health professionals who wish to learn the most up-to-date clinical data for these treatments in order to inform and integrate them into their own clinical practice.
SITC ACI attendees benefit from:
- Updates on the latest clinical advances in cancer immunotherapy, including data from recent scientific meetings and clinical trials
- An overview of common approaches to cancer immunotherapy and their related mechanisms
- Dedicated opportunities for clinicians to ask questions and receive direction on difficult cases
- Strategies for addressing the practical barriers to implementing immunotherapy (operations, reimbursement and management of emerging toxicities)
SITC ACI programs are certified for CME, CNE, CPE, and MOC credits.
Register today by visiting https://www.sitcancer.org/education/aci.